- Home
- ARCT vs NBB Comparison
ARCT vs NBB Comparison
Compare ARCT & NBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- NBB
- Stock Information
- Founded
- ARCT 2013
- NBB 2009
- Country
- ARCT United States
- NBB United States
- Employees
- ARCT N/A
- NBB N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- NBB Finance Companies
- Sector
- ARCT Health Care
- NBB Finance
- Exchange
- ARCT Nasdaq
- NBB Nasdaq
- Market Cap
- ARCT 526.5M
- NBB 470.6M
- IPO Year
- ARCT N/A
- NBB N/A
- Fundamental
- Price
- ARCT $10.59
- NBB $16.50
- Analyst Decision
- ARCT Buy
- NBB
- Analyst Count
- ARCT 10
- NBB 0
- Target Price
- ARCT $35.25
- NBB N/A
- AVG Volume (30 Days)
- ARCT 2.1M
- NBB 73.9K
- Earning Date
- ARCT 11-07-2025
- NBB 01-01-0001
- Dividend Yield
- ARCT N/A
- NBB 8.64%
- EPS Growth
- ARCT N/A
- NBB N/A
- EPS
- ARCT N/A
- NBB N/A
- Revenue
- ARCT $122,122,000.00
- NBB N/A
- Revenue This Year
- ARCT N/A
- NBB N/A
- Revenue Next Year
- ARCT $34.32
- NBB N/A
- P/E Ratio
- ARCT N/A
- NBB N/A
- Revenue Growth
- ARCT N/A
- NBB N/A
- 52 Week Low
- ARCT $8.04
- NBB $13.67
- 52 Week High
- ARCT $24.17
- NBB $16.66
- Technical
- Relative Strength Index (RSI)
- ARCT 31.16
- NBB 62.66
- Support Level
- ARCT $9.19
- NBB $16.06
- Resistance Level
- ARCT $12.10
- NBB $16.50
- Average True Range (ATR)
- ARCT 1.78
- NBB 0.16
- MACD
- ARCT -1.35
- NBB 0.01
- Stochastic Oscillator
- ARCT 9.36
- NBB 96.59
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
About NBB Nuveen Taxable Municipal Income Fund of Beneficial Interest
Nuveen Taxable Municipal Income Fund is a closed-end fund incorporated in the United States. Its primary objective is current income through investments in taxable municipal securities; the secondary objective is to seek enhanced portfolio value and total return. The fund invests a majority of its assets in a diversified portfolio of taxable municipal securities.